Brief: Cantargia Reports Favorable Outcome Of Patent Oppositions In Europe

Cantargia AB

05/07/2023 12:58

July 5 (Reuters) - Cantargia AB  CANTA.ST :
    * CANTARGIA REPORTS FAVORABLE OUTCOME OF PATENT OPPOSITIONS
IN
EUROPE
    * PATENT PROTECTION FOR CANTARGIA'S LEAD ASSET NADUNOLIMAB
AND A
BROAD RANGE OF VARIANT ANTIBODIES WAS MAINTAINED

Source text for Eikon:  ID:nMFNblzgF2 
Further company coverage:  CANTA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))